Is Pfizer (PFE) One of the Best Fortune 500 Dividend Stocks to Invest in Right Now?

With an annual dividend yield of 6.37%, Pfizer Inc. (NYSE:PFE) is included among the 10 Best Fortune 500 Dividend Stocks to Invest in Right Now.

Is Pfizer (PFE) One of the Best Fortune 500 Dividend Stocks to Invest in Right Now?

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company’s global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer health care products.

Pfizer Inc. (NYSE:PFE) declared a quarterly dividend of $0.43 per share on April 22, marking the 350th consecutive quarterly dividend paid by the company. The dividend is payable on June 12 to all shareholders as of the May 8 record.

Pfizer Inc. (NYSE:PFE) currently boasts an impressive annual dividend yield of 6.37% and reiterated its commitment to grow this figure even further over time in the last earnings call. PFE was also recently included in our list of the 14 Value Stocks with Highest Dividends.

Pfizer Inc. (NYSE:PFE) is targeting a full-year revenue of $59.5 billion to $62.5 billion, and adjusted EPS in the range of $2.80 to $3.00 for 2026. While its COVID products are expected to trend lower again this year, the company expects stable revenue contributions from its non-COVID product portfolio.

While we acknowledge the risk and potential of PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PFE and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Nuclear Energy Stocks to Buy for Dividends and 10 Best Global Stocks to Buy According to Wall Street Analysts

Disclosure: None. Follow Insider Monkey on Google News.